Shanghai Pharmaceuticals (601607.SH): Telmisartan Tablets receives approval number from the US FDA.

Zhtng cijng APP xn, shnghi yyo (601607.SH) fb gnggo, jnr, gngs xish chngzhu zhyo chng yuxin gngs (jinchng "chngzhu zhyo chng") shudo migu shpn yofng jind gunl j (jinchng "migu FDA") de tngzh, q guny t g ru lu pin de jinl xnyo shnqng ("ANDA", j migu fngzhyo shnqng) y hud zuzhng pzh shngsh. According to the Zhtng Caijing APP, Shanghai Pharmaceuticals (601607.SH) announced that recently, its subsidiary Changzhou Pharmaceutical Factory Co., Ltd. has received a notice from the U.S. Food and Drug Administration (FDA) that its abbreviated new drug application (ANDA) for telmisartan tablets has been finally approved for listing.